Bhooshi De Silva
Senior Vice President, Corporate Development & Strategy, PPD
Bhooshi De Silva joined PPD as senior vice president of corporate development and strategy in 2014. In this role, he serves as a member of PPD’s executive leadership team, leading the corporate development and strategy functions and co-leading the company’s strategy and innovation governance committee. He partners with the senior leadership team on key strategic initiatives and plays an important role in driving PPD’s evolution and growth. Since joining PPD, Bhooshi has led the organization in completing several strategic partnerships and acquisitions and in strengthening and expanding the company’s capabilities in priority focus areas. Bhooshi was instrumental in PPD’s 2016 acquisition of Evidera, a leading provider of evidence-based solutions to demonstrate the real-world effectiveness and value of biopharmaceutical products. Following the acquisition, Bhooshi’s role expanded to include oversight of Evidera, a wholly owned subsidiary of PPD, which now reports to him.
Prior to joining PPD, Bhooshi had spent 15 years in the biopharmaceutical industry where he held several leadership positions. He started his career at Pfizer, where his roles spanned R&D portfolio management, U.S. commercial development, and U.S. customer strategy and negotiations. In 2009, Bhooshi was named vice president of business development evaluation and strategy, leading a team in the evaluation of licensing, acquisitions and corporate strategic initiatives for Pfizer. Prior to joining PPD, he was head of corporate development, corporate strategy and head of International at Optimer Pharmaceuticals.
Bhooshi holds degrees in finance, economics and engineering from Stanford University, London School of Economics and Imperial College of Science & Technology in London, U.K.